Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | NEU2 | Q9Y3R4 | 3/20 | 0.46 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.46 |
| ▸ | NEU3 | Q9UQ49 | 2/20 | 0.46 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.46 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.43 |
| ▸ | MAG | P20916 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10339608 | 0.94 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL21408672 | 0.92 | NANP (0.56) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL30377089 | 0.92 | NANP (0.56) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL12391270 | 0.90 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL21138938 | 0.90 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL24630166 | 0.90 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL21162637 | 0.90 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL19316071 | 0.90 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL5428159 | 0.90 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL15253008 | 0.90 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0410883-B1 | Di-lysogangliosides derivatives | FIDIA SPA (IT) | 1999-03-31 | — | — | EP | claimed |
| EP-0433112-B1 | Modified gangliosides and the functional derivatives thereof | FIDIA SPA (IT) | 1998-10-28 | — | — | EP | claimed |
| EP-0410881-B1 | Semisynthetic ganglioside analogues | FIDIA SPA (IT) | 1997-09-17 | — | — | EP | claimed |
| US-5523294-A | THERAPY FOR NERVOUS SYSTEM DISORDERS | FIDIA S.P.A. (IT) | 1996-06-04 | — | — | US | claimed |
| EP-0373039-B1 | New lysoganglioside derivatives | FIDIA SPA (IT) | 1994-04-06 | — | — | EP | claimed |
| EP-0433112-A1 | Modified gangliosides and the functional derivatives thereof | FIDIA S.p.A. (IT) | 1991-06-19 | — | — | EP | claimed |
| EP-0410881-A2 | Semisynthetic ganglioside analogues | FIDIA S.p.A. (IT) | 1991-01-30 | — | — | EP | claimed |
| EP-0410883-A2 | Di-lysogangliosides derivatives | FIDIA S.p.A. (IT) | 1991-01-30 | — | — | EP | claimed |
| EP-0373039-A2 | New lysoganglioside derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | claimed |